Abstract
This is the first of two articles empirically detailing the working practices of regulators who are charged with overseeing biological research. Specifically, it considers how regulators from the Biological Agents Unit of the UK Health and Safety Executive review notifications and applications, carry out inspections of research centres, and enforce the law once breaches are uncovered. This first article focuses on the Unit's working practices before 9/11, and the second, forthcoming article focuses on the Unit's working practices after 9/11. I argue that an understanding of the implementation processes--that is, the strategies adopted by regulatory agencies and the styles employed by agency regulators in their interactions with those regulated--is critical to developing a coherent policy logic for the developing regulatory regime around biorisks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
